Published in AIDS Weekly, August 12th, 1996
Dr. Michael C. Smith, University Hospitals of Cleveland, Ohio, and colleagues believe that the corticosteroid-related side effects of prednisone treatment do not prohibit its use in HIV positive patients with nephropathy. In 19 consecutive patients diagnosed with HIV associated nephropathy, Smith administered prednisone at 60 mg/d for two to 11 weeks. This was followed by a tapering course of prednisone over two to 26 weeks.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.